Pharma News

Sun Pharma has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company Lilly for expanding access to Lillys drug, baricitinib in India. Sun Pharma will manufacture and distribute the drug in India.

U.S. Food and Drug Administration, FDA, has expanded the Emergency Use Authorization, EUA, for Pfizer COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in the U.S. for use in this age group.

Masimo announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr.

The Drugs Controller General of India, DCGI, has given permission for the emergency use of 2 deoxyD-glucose, 2-DG medicine as an adjunct therapy in moderate to severe Covid-19 cases.

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.

As India faces a second wave of COVID-19, PerkinElmer Inc., a global leader committed to innovating for a healthier world, will donate 1 million PerkinElmer COVID-19 Antigen Tests to the Government of India to help accelerate testing capabilities across the country. With the support of the US-India Strategic Partnership Forum, PerkinElmer COVID-19 Antigen Test kits will be distributed to government hospitals and testing centers across 10 states of India.

Eli Lilly and Company announces new initiatives to help COVID-19 patients in India as part of its commitment to bring the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world. Lilly is offering donations of baricitinib to the Indian government through Direct Relief while simultaneously working with local Indian pharmaceutical companies to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic.

Alligator Bioscience announced that preclinical data on its agonist anti-CD40 antibody mitazalimab has been published in the scientific journal Cancer Immunology, Immunotherapy.

The published data show that mitazalimab activates dendritic cells and tumor-reactive T cells resulting in enhanced anti-tumor efficacy in combination with a model cancer vaccine.

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, have used gene therapy to prevent learning and memory loss in a mouse model of Alzheimers disease, a key step toward eventually testing the approach in humans with the neurodegenerative disease. The findings are published online in advance of the June 11, 2021 issue of Molecular Therapy-Methods & Clinical Development. 

Indo UK Clinics an integral part of one of the largest healthcare projects in the world encompassing 5000 clinics and 11 medicities pan-India using NHS expertise, equipment and suppliers gets started with first Indo UK Clinic becoming operational in Ludhiana, Punjab. The objective of setting up 5000 diagnostic centers and clinics is a part of inter-governmental discussions between India and the UK at Commonwealth Heads of Government Meeting (CHOGM) level in 2018.